Takeaway

• In an educational session presented at the AACR 2022, Dr David Rimm, Dr Janis Taube, and Dr Tomas Kirchhoff discussed the importance of predictive biomarkers in the adjuvant immunotherapy setting.
• Although adjuvant immunotherapy may be highly effective in a subset of patients, it involves a risk-benefit calculation.
• Predictive biomarkers...